Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Thyroid Gland Carcinoma: early-phase trial registry

4 of 4 indexed Thyroid Gland Carcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Thyroid Gland Carcinoma: 4 US clinical trials tracked, 4 recruiting.

Thyroid Gland Carcinoma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Jonsson Comprehensive Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition thyroid-gland-carcinoma

OPEN 4 | RECR 100% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Thyroid Gland Carcinoma (thi…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Thyroid Gland Carcinoma

Thyroid Gland Carcinoma lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thyroid Gland Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Thyroid Gland Carcinoma is recruiting above its size-band peers.

    4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Thyroid Gland Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Electronic Health Record Review Other
2 trials
Needle Biopsy Procedure
1 trials
Diagnostic Procedure Procedure
1 trials
Hyperpolarized Carbon C 13 Pyruvate Drug
1 trials
Non-Interventional Study Other
1 trials
Magnetic Resonance Imaging Procedure
1 trials
Biospecimen Collection Procedure
1 trials

US sites by state

Facility locations filed on Thyroid Gland Carcinoma trials. A trial with sites in several states counts in each.

California 2 trials
Texas 1 trials
Minnesota 1 trials
Florida 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Thyroid Gland Carcinoma page

4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thyroid Gland Carcinoma condition card totals 4 registered trials; most-linked intervention Electronic Health Record Review; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.